Lawrence Brandt, MD, on Fecal Microbiota Transplant Study, Part I
Feb 03, 2012 | Matthew Turowski
Lawrence Brandt, MD, professor of medicine and surgery at the Albert Einstein College of Medicine in New York City, discusses a study on the outcomes of fecal microbiota transplants on almost 100 patients across the country with refractory Clostridium difficile colitis. He explains that 91 percent of the patients experienced prompt relief. Including those who underwent a second transplant or a post-transplant course of medication, 98.3 percent of the patients experienced relief. This video was shot at the annual scientific conference of the American College of Gastroenterology.
Deaths and infections traced to duodenoscopes contaminated with carbapenem-resistant enterobacteriaceae infections are on the rise. The ECRI Institute, a nonprofit research and testing lab, today put out a "high priority hazard report" on procedures for cleaning the devices. It isn't easy.
Many US politicians and media outlets hyped the threat of US cases of Ebola last year, according to a newly written personal account by Craig Spencer, MD, MPH, the last American Ebola patient treated in the United States. He also believes that officials and the media unnecessarily maligned those who were risking their lives to combat the West African epidemic.